Prophylaxis of infective endocarditis: current tendencies, continuing controversies

Area of Science:

• Cardiology
• Infectious Diseases
• Public Health

Background:

• Infective endocarditis is a serious condition with high mortality, often stemming from bacteremia and underlying heart issues.
• Current infective endocarditis prophylaxis strategies lack robust clinical trial evidence supporting their efficacy.
• Existing recommendations are based on presumed disease mechanisms rather than proven effectiveness.

Purpose of the Study:

• To critically review decades of data on infective endocarditis prophylaxis.
• To challenge the established principles behind current prophylaxis guidelines.
• To analyze the rationale for recent reductions in prophylaxis indications.

Main Methods:

• Systematic review of historical and contemporary data on infective endocarditis.
• Analysis of the pathophysiology and risk factors for infective endocarditis.
• Evaluation of the evidence supporting antibiotic prophylaxis before procedures.

Main Results:

• The efficacy of infective endocarditis prophylaxis has not been confirmed by randomized clinical trials.
• Everyday bacteremia likely plays a significant role in infective endocarditis development.
• A very large number of prophylaxis doses are required to prevent a single case.

Conclusions:

• Infective endocarditis prophylaxis recommendations are being revised due to a lack of strong scientific evidence.
• The focus is narrowing to high-risk cardiac patients, particularly before dental procedures.
• Future guidelines emphasize evidence-based approaches and risk stratification for prophylaxis.